Free Anti-Vedolizumab
Detecting the development of Anti-drug antibodies (ADAs) against Vedolizumab in patients being treated with Vedolizumab for chronic autoimmune and inflammatory conditions
Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Free Anti-Vedolizumab can detect the presence of anti-drug antibodies against Vedolizumab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 10 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.
About Using Reagent
-
Sample Types
Whole blood, Serum -
Reaction Time
10 mins -
Detection Range
10~250 ng/mL -
Intended Use
Quantitative determination of free antibodies against Vedolizumab including in human whole blood/serum.
In Your Medical Field
AFIAS Free Anti-Vedolizumab detects anti-drug antibodies against Vedolizumab in just 10 minutes using a small amount of blood. It provides valuable insights into patients’ response to the treatment of Vedolizumab.